Perfuze yesterday announced that the FDA granted its Millipede CIS technology Breakthrough Device Designation.
Millipede CIS is a catheter technology that removes clots from the brain after an acute ischemic stroke. The Breakthrough Device Designation was granted based on its potential to offer advantages over other alternative treatment of acute ischemic stroke, according to the company.
Perfuze raised more than $3 million earlier this year in a seed round for the Millipede development.
